X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
hereditary angioedema (16) 16
humans (14) 14
complement c1 inhibitor protein - therapeutic use (9) 9
icatibant (9) 9
angioedemas, hereditary - drug therapy (8) 8
immunology (8) 8
plasma-derived c1-inhibitor (8) 8
acute attacks (7) 7
angioneurotic edema (7) 7
prophylaxis (7) 7
allergy (6) 6
angioedema (6) 6
female (6) 6
male (6) 6
middle aged (6) 6
safety (6) 6
therapy (6) 6
adolescent (5) 5
adult (5) 5
angioneurotic-edema (5) 5
attacks (5) 5
bradykinin - analogs & derivatives (5) 5
c1 inhibitor deficiency (5) 5
child (5) 5
deficiency (5) 5
diagnosis (5) 5
ecallantide (5) 5
management (5) 5
receptor antagonist (5) 5
treatment outcome (5) 5
bradykinin - therapeutic use (4) 4
c1-inhibitor concentrate (4) 4
concentrate (4) 4
edema (4) 4
internal medicine (4) 4
long-term prophylaxis (4) 4
plasma-derived c1 inhibitor (4) 4
practice guidelines as topic (4) 4
self-administration (4) 4
tranexamic acid (4) 4
treatment (4) 4
allergy and immunology (3) 3
angioedemas, hereditary - diagnosis (3) 3
angioedemas, hereditary - epidemiology (3) 3
berinert (3) 3
bradykinin (3) 3
bradykinin b2 receptor antagonist (3) 3
c1 inhibitor concentrate (3) 3
c1-inhibitor (3) 3
c1-inhibitor deficiency (3) 3
care and treatment (3) 3
child, preschool (3) 3
children (3) 3
complement c1 inhibitor protein - adverse effects (3) 3
consensus report (3) 3
drug therapy (3) 3
esterase inhibitor (3) 3
hereditary angioedema types i and ii - drug therapy (3) 3
kallikrein inhibitor (3) 3
medicine & public health (3) 3
medicine, research & experimental (3) 3
patients (3) 3
peptides - therapeutic use (3) 3
pharmacology & pharmacy (3) 3
plasma (3) 3
prospective studies (3) 3
replacement therapy (3) 3
young adult (3) 3
acid therapy (2) 2
acute treatment (2) 2
age (2) 2
aged (2) 2
allergies (2) 2
androgens (2) 2
androgens - therapeutic use (2) 2
angioedemas, hereditary - prevention & control (2) 2
bradykinin - metabolism (2) 2
bradykinin receptor antagonists (2) 2
c1 inhibitor (2) 2
complement c1 inhibitor protein - administration & dosage (2) 2
complement inactivating agents - therapeutic use (2) 2
data collection (2) 2
dosing (2) 2
efficacy (2) 2
emergency (2) 2
endocrinology (2) 2
fresh-frozen plasma (2) 2
hepatitis-c (2) 2
hereditary angioedema types i and ii - physiopathology (2) 2
hereditary angioneurotic-edema (2) 2
home care services (2) 2
home therapy (2) 2
human c1-inhibitor (2) 2
inhibitor drugs (2) 2
international consensus algorithm (2) 2
laryngeal edema (2) 2
missense mutations (2) 2
mutation (2) 2
nanofiltration (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 2017, Volume 5, Issue 5, pp. 1307 - 1313
Journal Article
Journal Article
Biologics in Therapy, ISSN 2190-9164, 1/2012, Volume 2, Issue 1, pp. 1 - 17
Hereditary angioedema resulting from the deficiency of the C1 inhibitor (HAE-C1-INH) is a rare, but potentially life-threatening disorder characterized by... 
Plasma derived | Rheumatology | Prophylaxis | Oncology | Internal Medicine | Tolerability | Nanofiltered | C1-inhibitor deficiency | Hereditary angioedema | Treatment | Medicine & Public Health | Gastroenterology | Infectious Diseases | Human C1 inhibitor concentrate | Safety | Endocrinology
Journal Article
Allergy & Rhinologys, ISSN 2152-6575, 3/2017, Volume 8, Issue 1, pp. 13 - e19
Background The plasma-derived, pasteurized, nanofiltered C1-inhibitor concentrate (pnfC1-INH) is approved in the United States as an intravenous (IV) on-demand... 
hereditary angioedema | long-term prophylaxis | registry | thromboembolic events | Berinert | self-administration | safety | plasma-derived C1-inhibitor | dosing | efficacy
Journal Article
The journal of allergy and clinical immunology. In practice, ISSN 2213-2198, 03/2020
Plasma-derived C1-inhibitor (pdC1-INH) is a first-line therapy for hereditary angioedema (HAE) with C1-inhibitor deficiency (C1-INH-HAE) in pediatric patients.... 
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 04/2013, Volume 14, Issue 5, pp. 571 - 586
Introduction: Bradykinin-mediated angioedema is characterized by subcutaneous and/or submucosal edema formation without wheals and pruritus. It is linked to... 
treatment | attenuated androgens | recombinant human C1-inhibitor concentrate | antifibrinolytics | plasma derived C1-inhibitor concentrate | bradykinin-mediated angioedema | bradykinin B2 receptor antagonist | kallikrein inhibitor | Kallikrein inhibitor | Antifibrinolytics | Attenuated androgens | Recombinant human C1-inhibitor concentrate | Treatment | Bradykinin B2 receptor antagonist | Bradykinin-mediated angioedema | Plasma derived C1-inhibitor concentrate | ACUTE ATTACKS | HEREDITARY ANGIONEUROTIC-EDEMA | SHORT-TERM PROPHYLAXIS | ACQUIRED C1-INHIBITOR DEFICIENCY | RECEPTOR ANTAGONIST | TRANEXAMIC ACID | C1 INHIBITOR DEFICIENCY | FACTOR-XII GENE | PHARMACOLOGY & PHARMACY | FRESH-FROZEN PLASMA | ESTERASE INHIBITOR | Recombinant Proteins - therapeutic use | Antifibrinolytic Agents - therapeutic use | Complement C1 Inhibitor Protein - therapeutic use | Bradykinin - metabolism | Hereditary Angioedema Types I and II - physiopathology | Humans | Hereditary Angioedema Type III - metabolism | Capillary Permeability - drug effects | Hereditary Angioedema Types I and II - metabolism | Treatment Outcome | Bradykinin - antagonists & inhibitors | Receptors, Bradykinin - metabolism | Signal Transduction - drug effects | Bradykinin Receptor Antagonists | Hereditary Angioedema Types I and II - drug therapy | Hereditary Angioedema Type III - drug therapy | Androgens - therapeutic use | Hereditary Angioedema Types I and II - diagnosis
Journal Article
The journal of allergy and clinical immunology. In practice, ISSN 2213-2198, 04/2020
Consensus guidelines recommend plasma-derived C1 inhibitor (C1-INH) as first-line treatment in pregnant women with hereditary angioedema (HAE). We conducted a... 
Journal Article
Journal Article
Current Opinion in Pediatrics, ISSN 1040-8703, 10/2012, Volume 24, Issue 5, pp. 638 - 646
Purpose of review To review and update the management and understanding of hereditary angioedema (HAE), while integrating insights into pediatric subtleties... 
hereditary angioedema | recombinant human C1 esterase inhibitor | icatibant |